Disease category |
Induction therapy |
Maintenance therapy |
Localized disease |
Methotrexate and steroids |
Low-dose steroids plus azathioprine or leflunomide or methotrexate |
Early Systemic |
Methotrexate or cyclophosphamide and steroids |
Low-dose steroids plus azathioprine |
Generalized disease |
Cyclophosphamide and steroids |
Low-dose steroids plus azathioprine or mycophenolate mofetil |
Severe disease |
Cyclophosphamide and steroids plus plasma exchange |
Low-dose steroids plus azathioprine or mycophenolate mofetil |
Refractory disease |
Deoxyspergualin, mycophenolate mofetil, antithymocyte globulin or rituximab |
No consensus |